August

Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research Tim Lahm, Steven M. Kawut Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017
Assessing risk in pulmonary arterial hypertension: what we know, what we don't Raymond L. Benza, Harrison W. Farber, Mona Selej, Mardi Gomberg-Maitland Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Licence to kill senescent cells in idiopathic pulmonary fibrosis? Arnaud A. Mailleux, Bruno Crestani Eur Respir J, 50 (2) 1701360; 10.1183/13993003.01360-2017
Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues David Montani, Andrei Seferian, Florence Parent, Marc Humbert Eur Respir J, 50 (2) 1701319; 10.1183/13993003.01319-2017
Effects of sleep apnoea therapy on blood pressure and metabolism: a CPAP sex gap? Frédéric Gagnadoux, Pascaline Priou, Nicole Meslier, Wojciech Trzepizur Eur Respir J, 50 (2) 1700987; 10.1183/13993003.00987-2017
The Art of Breathing: Saturation Gary P. Anderson Eur Respir J, 50 (2) 1705002; 10.1183/13993003.05002-2017
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects Xinping Chen, Eric D. Austin, Megha Talati, Joshua P. Fessel, Eric H. Farber-Eger, Evan L. Brittain, Anna R. Hemnes, James E. Loyd, James West Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Marius M. Hoeper, Tilmann Kramer, Zixuan Pan, Christina A. Eichstaedt, Jens Spiesshoefer, Nicola Benjamin, Karen M. Olsson, Katrin Meyer, Carmine Dario Vizza, Anton Vonk-Noordegraaf, Oliver Distler, Christian Opitz, J. Simon R. Gibbs, Marion Delcroix, H. Ardeschir Ghofrani, Doerte Huscher, David Pittrow, Stephan Rosenkranz, Ekkehard Grünig Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Athénaïs Boucly, Jason Weatherald, Laurent Savale, Xavier Jaïs, Vincent Cottin, Grégoire Prevot, François Picard, Pascal de Groote, Mitja Jevnikar, Emmanuel Bergot, Ari Chaouat, Céline Chabanne, Arnaud Bourdin, Florence Parent, David Montani, Gérald Simonneau, Marc Humbert, Olivier Sitbon Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris Boris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, Shreosi Sanyal, Pierre-Yves Brillet, Michel Brauner, Marianne Kambouchner, Sophie Huynh, Jean Marc Naccache, Raphael Borie, Jacques Piquet, Arsène Mekinian, Jerôme Virally, Yurdagul Uzunhan, Jacques Cadranel, Bruno Crestani, Olivier Fain, Francois Lhote, Robin Dhote, Nathalie Saidenberg-Kermanac'h, Paul-André Rosental, Dominique Valeyre, Hilario Nunes Eur Respir J, 50 (2) 1602419; 10.1183/13993003.02419-2016
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Myriam Delaunay, Jacques Cadranel, Amélie Lusque, Nicolas Meyer, Valérie Gounant, Denis Moro-Sibilot, Jean-Marie Michot, Judith Raimbourg, Nicolas Girard, Florian Guisier, David Planchard, Anne-Cécile Metivier, Pascale Tomasini, Eric Dansin, Maurice Pérol, Marion Campana, Oliver Gautschi, Martin Früh, Jean-David Fumet, Clarisse Audigier-Valette, Sébastien Couraud, Stéphane Dalle, Marie-Thérèse Leccia, Marion Jaffro, Samia Collot, Grégoire Prévot, Julie Milia, Julien Mazieres Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Mareike Lehmann, Martina Korfei, Kathrin Mutze, Stephan Klee, Wioletta Skronska-Wasek, Hani N. Alsafadi, Chiharu Ota, Rita Costa, Herbert B. Schiller, Michael Lindner, Darcy E. Wagner, Andreas Günther, Melanie Königshoff Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea Francisco Campos-Rodriguez, Monica Gonzalez-Martinez, Angeles Sanchez-Armengol, Bernabe Jurado-Gamez, Jose Cordero-Guevara, Nuria Reyes-Nuñez, Maria F. Troncoso, Araceli Abad-Fernandez, Joaquin Teran-Santos, Julian Caballero-Rodriguez, Mercedes Martin-Romero, Ana Encabo-Motiño, Lirios Sacristan-Bou, Javier Navarro-Esteva, Maria Somoza-Gonzalez, Juan F. Masa, Maria A. Sanchez-Quiroga, Beatriz Jara-Chinarro, Belen Orosa-Bertol, Miguel A. Martinez-Garcia Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017
Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease Lies Lahousse, Leen J.M. Seys, Guy F. Joos, Oscar H. Franco, Bruno H. Stricker, Guy G. Brusselle Eur Respir J, 50 (2) 1602470; 10.1183/13993003.02470-2016
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice Pascale Tomasini, Solenn Brosseau, Julien Mazières, Jean-Philippe Merlio, Michèle Beau-Faller, Jean Mosser, Marie Wislez, L'Houcine Ouafik, Benjamin Besse, Isabelle Rouquette, Didier Debieuvre, Fabienne Escande, Virginie Westeel, Clarisse Audigier-Valette, Pascale Missy, Alexandra Langlais, Frank Morin, Denis Moro-Sibilot, Gérard Zalcman, Fabrice Barlesi Eur Respir J, 50 (2) 1700514; 10.1183/13993003.00514-2017
The emerging role of transient receptor potential channels in chronic lung disease Maria G. Belvisi, Mark A. Birrell Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016
More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Karen M. Olsson, Jan Fuge, Katrin Meyer, Tobias Welte, Marius M. Hoeper Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017
Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Pierre-Régis Burgel, Gil Bellis, J. Stuart Elborn Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years Sara C. Buttery, Divya Mohan, Marie Fisk, Nicholas S. Hopkinson, Ruth Tal-Singer, Ian B. Wilkinson, Michael I. Polkey Eur Respir J, 50 (2) 1700707; 10.1183/13993003.00707-2017
The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible? Cynthia B.E. Chee, Kyi-Win KhinMar, Li-H. Sng, Roland Jureen, Jeffery Cutter, Vernon J.M. Lee, Yee-Tang Wang Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017
Concern of underdiagnosing asthma–COPD overlap syndrome if age limit of 40 years for asthma is used Minna Tommola, Pinja Ilmarinen, Leena E. Tuomisto, Hannu Kankaanranta Eur Respir J, 50 (2) 1700871; 10.1183/13993003.00871-2017
Concern of underdiagnosing asthma–COPD overlap syndrome if age limit of 40 years for asthma is used Don D. Sin, Janice M. Leung, Michael E. Wechsler Eur Respir J, 50 (2) 1701120; 10.1183/13993003.01120-2017
ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids Eur Respir J, 50 (2) 17E5002; 10.1183/13993003.E5002-2017
Fooling the brain to alleviate dyspnoea Capucine Morélot-Panzini Eur Respir J, 50 (2) 1701383; 10.1183/13993003.01383-2017
Neuropsychiatric adverse effects of montelukast in children Pierre Ernst, Geneviève Ernst Eur Respir J, 50 (2) 1701020; 10.1183/13993003.01020-2017
ERS statement on protracted bacterial bronchitis in children Ahmad Kantar, Anne B. Chang, Mike D. Shields, Julie M. Marchant, Keith Grimwood, Jonathan Grigg, Kostas N. Priftis, Renato Cutrera, Fabio Midulla, Paul L.P. Brand, Mark L. Everard Eur Respir J, 50 (2) 1602139; 10.1183/13993003.02139-2016
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension Sean Gaine, Kelly Chin, Gerry Coghlan, Richard Channick, Lilla Di Scala, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Irene M. Lang, Vallerie McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simonneau, Olivier Sitbon, Victor F. Tapson, Marius M. Hoeper Eur Respir J, 50 (2) 1602493; 10.1183/13993003.02493-2016
Contributions of a hand-held fan to self-management of chronic breathlessness Tim Luckett, Jane Phillips, Miriam J. Johnson, Morag Farquhar, Flavia Swan, Teresa Assen, Priyanka Bhattarai, Sara Booth Eur Respir J, 50 (2) 1700262; 10.1183/13993003.00262-2017
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic, Francine M. Ducharme Eur Respir J, 50 (2) 1700148; 10.1183/13993003.00148-2017
Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control Alain Michils, Amaryllis Haccuria, Sebastien Michiels, Alain Van Muylem Eur Respir J, 50 (2) 1700392; 10.1183/13993003.00392-2017
Fevipiprant, an oral prostaglandin DP₂ receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids Eric D. Bateman, Alfredo G. Guerreros, Florian Brockhaus, Björn Holzhauer, Abhijit Pethe, Richard A. Kay, Robert G. Townley Eur Respir J, 50 (2) 1700670; 10.1183/13993003.00670-2017
Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma Marina Pretolani, David Soussan, Isabelle Poirier, Gabriel Thabut, Michel Aubier Eur Respir J, 50 (2) 1700019; 10.1183/13993003.00019-2017
Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis Claudia C. Dobler, Kelvin Cheung, John Nguyen, Andrew Martin Eur Respir J, 50 (2) 1700157; 10.1183/13993003.00157-2017
Treatment of limited disease small cell lung cancer: the multidisciplinary team Markus Glatzer, Achim Rittmeyer, Joachim Müller, Isabelle Opitz, Alexandros Papachristofilou, Ioannis Psallidas, Martin Früh, Diana Born, Paul Martin Putora Eur Respir J, 50 (2) 1700422; 10.1183/13993003.00422-2017
Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis Ian N. Glaspole, Alice L. Watson, Heather Allan, Sally Chapman, Wendy A. Cooper, Tamera J. Corte, Samantha Ellis, Christopher Grainge, Nicole Goh, Peter Hopkins, Gregory Keir, Sacha Macansh, Annabelle Mahar, Yuben Moodley, Paul N. Reynolds, Christopher J. Ryerson, E. Haydn Walters, Christopher J. Zappala, Anne E. Holland Eur Respir J, 50 (2) 1700168; 10.1183/13993003.00168-2017
Heredity of supraglottic exercise-induced laryngeal obstruction Emil Schwarz Walsted, Jeppe Hvedstrup, Hans Eiberg, Vibeke Backer Eur Respir J, 50 (2) 1700423; 10.1183/13993003.00423-2017
Prenatal stress exposure is associated with increased dyspnoea perception in adulthood Andreas von Leupoldt, Eline Mangelschots, Nils Georg Niederstrasser, Marijke Braeken, Thibo Billiet, Bea R.H. Van den Bergh Eur Respir J, 50 (2) 1700642; 10.1183/13993003.00642-2017
Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations Hartmut Grasemann, Pierluigi Ciet, Reshma Amin, Nancy McDonald, Michelle Klingel, Harm A.W.M. Tiddens, Felix Ratjen, Lars Grosse-Wortmann Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017
How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Rebecca R. Vanderpool, Ankit A. Desai, Shannon M. Knapp, Marc A. Simon, Aiden Abidov, Jason X.-J. Yuan, Joe G.N. Garcia, Lillian M. Hansen, Steven R. Knoper, Robert Naeije, Franz P. Rischard Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan Meng-Rui Lee, Cheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, Lih-Yu Chang, Kai-Lun Yu, Jen-Chung Ko, Jann-Yuan Wang, Jann-Tay Wang, Li-Na Lee Eur Respir J, 50 (2) 1700851; 10.1183/13993003.00851-2017
Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives Denis Monneret, Jean-Philippe Bastard Eur Respir J, 50 (2) 1701038; 10.1183/13993003.01038-2017
Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives Silke Ryan Eur Respir J, 50 (2) 1701182; 10.1183/13993003.01182-2017
D_LCO: adjust for lung volume, standardised reporting and interpretation Douglas C. Johnson Eur Respir J, 50 (2) 1700940; 10.1183/13993003.00940-2017
D_LCO: adjust for lung volume, standardised reporting and interpretation Brian L. Graham, Vito Brusasco, Felip Burgos, Brendan G. Cooper, Robert Jensen, Adrian Kendrick, Neil R. MacIntyre, Bruce R. Thompson, Jack Wanger Eur Respir J, 50 (2) 1701144; 10.1183/13993003.01144-2017